The PSEN2 gene gives cells instructions for part of a protein-cutting system that helps brain cells process important signals. This gene plays an important role in how nerve cells handle amyloid precursor protein, which can create amyloid beta, a protein fragment linked to Alzheimer’s disease. Some pathogenic variants in the PSEN2 gene are linked to rare inherited forms of Alzheimer’s disease, sometimes starting earlier in adult life. Most people with Alzheimer’s do not have a PSEN2 variant.
What is a gene?
Genes are sections of DNA that give your cells instructions for making molecules or managing processes in the body. Some genes carry the information needed to produce proteins, which do much of the work inside cells. Others mainly regulate when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
PSEN2Gene function
What if the gene works
Your cells use the PSEN2 gene to help cut certain proteins within cell membranes. This supports cell signaling and normal protein handling.
Risk
What if the gene does not work
Rare pathogenic variants in the PSEN2 gene are linked to inherited Alzheimer disease, usually beginning in adulthood. Milder and more severe variants can affect how much protein function is changed, which may influence when memory symptoms start and how much they affect daily life.
Treatment
What does that mean for your treatment
No PSEN2-specific treatment or management approach is currently established for people with a pathogenic variant in the PSEN2 gene. In research, the PSEN2 gene is being studied in Alzheimer disease pathways, and related amyloid-targeting approaches have been explored, but they do not currently guide treatment choices based on PSEN2 status.
Conditions associated with PSEN2
Gene function
What if the gene works
Your cells use the PSEN2 gene as part of a system that trims certain proteins after they are made. This helps cells send messages and manage routine protein turnover at the cell surface. Understanding how the PSEN2 gene works in cells makes its day to day role easier to see.
The PSEN2 gene provides a key part of gamma secretase (a protein team that cuts certain proteins in the cell membrane). This careful trimming changes how those proteins work and what happens to them next.
By cutting selected membrane proteins, the PSEN2 gene helps release signals that let cells communicate and respond to change. One important pathway is Notch, a signaling system that supports normal cell decisions and tissue upkeep.
One protein handled by this system is APP, a normal cell protein also called amyloid precursor protein. This is part of how the PSEN2 gene helps cells process proteins in an orderly, step by step way.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the PSEN2 gene change presenilin 2, altering γ-secretase, a protein-cutting complex, and shifting how amyloid precursor protein is processed. PSEN2 gene variants linked to early onset Alzheimer disease often raise the relative amount of amyloid-β42, a stickier protein fragment that can build up in the brain. Some changes have milder effects on this process, while more disruptive variants may have a stronger effect and can be linked to earlier symptoms in some families.
How variants are linked to conditions
Certain rare pathogenic variants in the PSEN2 gene can cause familial early-onset Alzheimer’s disease, an inherited form of dementia that often begins before age 65, although the age of onset can vary. The best-established PSEN2 gene link to Alzheimer’s disease is this rare family-based form, not the much more common late-onset Alzheimer’s seen in the general population. Some PSEN2 variants found on testing do not clearly predict disease on their own and need expert interpretation in family context.
A variant is not necessarily a diagnosis
Variants are a common and normal feature of human biology. Most do not directly affect health and simply contribute to the natural range of human differences. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
For clearly harmful changes in the PSEN2 gene, risk is driven mainly by the variant itself, and the age symptoms begin can vary from one family to another. There is not enough evidence to say that specific lifestyle changes lower this inherited risk, although avoiding smoking and managing heart and blood vessel health still supports overall brain health.
Inheritance of PSEN2 variants
For families affected by PSEN2-related Alzheimer disease, the PSEN2 inheritance pattern is usually autosomal dominant. This means a parent carrying a disease-causing variant in the PSEN2 gene can pass it to a son or daughter, and each child has a 50% chance of inheriting that same variant. The PSEN2 gene is on chromosome 1, so this inheritance pattern affects males and females similarly. Not everyone who inherits a PSEN2 variant will develop symptoms at the same age, but the way the variant is passed through a family remains the same.
What does my PSEN2 result mean for my family?
A disease-causing change in the PSEN2 gene is usually passed through families in a dominant way, so close relatives such as parents, brothers, sisters, and children may also carry the same change. In many families, each child of someone with the variant has a 1 in 2, or 50%, chance of inheriting it. This can matter most in families with early-onset Alzheimer’s disease, where symptoms start younger than usual.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the PSEN2 gene usually uses a blood or saliva sample, which a lab reads to look for changes in your DNA. Results can show whether a variant was found, whether it is known to cause disease, or whether its meaning is still uncertain.
When should I consider getting a genetic test?
Testing for the PSEN2 gene may be considered when Alzheimer’s disease starts unusually early in a family, especially before age 65 and across generations, or when a close relative has a known PSEN2 change. A result can help clarify whether the condition is inherited in that family.
A genetic result is only one part of your health story
Genetic findings can be very informative, but how much they explain depends on the condition and on the specific type of variant. Over time, the way the body functions is also shaped by factors like lifestyle, environment, age, and medical history. In some conditions, especially those affected by many genes, genetic information provides context rather than certainty and makes the most sense when viewed with the rest of a person’s care. In other situations, a genetic result can give a clear answer. For medication response, genetic results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same medication may work well for one person, seem less helpful for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medications. It studies gene drug patterns to help explain why the same treatment can work differently from one person to another. With many medicines, genes influence both how the body handles a drug and how strong its effects may be. This information can support treatment decisions that are more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the PSEN2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. Questions about medicines, side effects, or treatment changes are best discussed with your doctor or pharmacist.
History
The PSEN2 gene entered Alzheimer’s research in the mid 1990s, when scientists were searching for inherited causes of rare early onset forms of the condition. Building on this early work, researchers identified PSEN2 in 1995 after earlier discoveries involving APP and the PSEN1 gene. Its discovery mattered because it showed that more than one inherited pathway could lead to familial Alzheimer disease, helping reshape how researchers thought about the illness. Early reports linked PSEN2 variants to a small number of families, including a well known Volga German kindred that became important in genetic studies. Since then, the PSEN2 gene has remained part of the history of Alzheimer genetics, especially in understanding rare inherited cases.